Vaccination with a CD4+ and CD8+ T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis.
Dias DS, Ribeiro PAF, Martins VT, Lage DP, Costa LE, Chávez-Fumagalli MA, Ramos FF, Santos TTO, Ludolf F, Oliveira JS, Mendes TAO, Silva ES, Galdino AS, Duarte MC, Roatt BM, Menezes-Souza D, Teixeira AL, Coelho EAF.
Dias DS, et al. Among authors: teixeira al.
Transl Res. 2018 Oct;200:18-34. doi: 10.1016/j.trsl.2018.05.001. Epub 2018 May 22.
Transl Res. 2018.
PMID: 29908151